Michael Rosenblatt's Net Worth
$5.64 Million
Who is Michael Rosenblatt?
Michael Rosenblatt has an estimated net worth of $5.64 Million. This is based on reported shares across multiple companies, which include Merck & Co. Inc., Azenta, Inc., Rubius Therapeutics, Inc., and Axcella Health Inc..
SEC CIK
Michael Rosenblatt's CIK is 0001478797
Past Insider Trading and Trends
2010 was Michael Rosenblatt's most active year for acquiring shares with 4 total transactions. Michael Rosenblatt's most active month to acquire stocks was the month of April. 2013 was Michael Rosenblatt's most active year for disposing of shares, totalling 4 transactions. Michael Rosenblatt's most active month to dispose stocks was the month of April. 2016 saw Michael Rosenblatt paying a total of $392,858.26 for 58,672 shares, this is the most they've acquired in one year. In 2013 Michael Rosenblatt cashed out on 27,418 shares for a total of $1,159,868.68, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Merck & Co. Inc. (MRK) Snapshot price: $117.36
Exec V-P & Chief Med Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
| +23.17% | 7.74K |
$50.77 | $392,858.26 | 41.13K |
Feb 22
| |||
Form 4
| +5.98% | 1.84K |
$59.86 | -$118,522.80 | 32.55K |
May 1 - May 2
| |||
Form 4
| +19.63% | 5K |
$58.30 | $291,558.30 | 30.48K |
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
| +10.19% | 2.3K |
$58.22 | -$104,737.78 | 24.92K |
May 4
| |||
Form 4
| +27.99% | 4.91K |
$56.18 | $275,675.26 | 22.44K |
Feb 24
| |||
Form 4
| +14.45% | 2.16K |
$44.98 | -$104,488.54 | 17.07K |
May 6 - May 7
| |||
Form 4
| +57.46% | 5.39K |
$42.52 | $229,267.84 | 14.78K |
Feb 25
| |||
Form 4
|
∞
| 9.38K |
$41.42 | -$232,614.72 | 9.38K |
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Azenta, Inc. (AZTA) Snapshot price: $47.57
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +23.31% | 2.46K |
$65.93 | $162,517.45 | 13.04K |
Feb 12
| |||
Form 4
| +51.69% | 3.6K |
—
|
—
| 10.58K |
Feb 13
| |||
Form 4
| +38.05% | 1.92K |
—
|
—
| 6.97K |
Feb 11
| |||
Form 4
| -35.92% | -2.83K |
$114.13 | -$323,102.03 | 5.05K |
Nov 12
| |||
Form 4
| -18.25% | -1.76K |
$90.00 | -$158,400.00 | 7.88K |
May 13
| |||
Form 4
| +22.33% | 1.76K |
—
|
—
| 9.64K |
Feb 5
| |||
Form 4
| +56.05% | 2.83K |
—
|
—
| 7.88K |
Feb 11
| |||
Form 4
| +396.17% | 4.03K |
—
|
—
| 5.05K |
Feb 8
| |||
Form 4
|
∞
| 1.02K |
—
|
—
| 1.02K |
Sep 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Rubius Therapeutics, Inc. (RUBY) Snapshot price: $0.053
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Axcella Health Inc. (AXLA) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||